Categories: Health

Pfizer can’t sell vaccine in India as it is not ready to go for local trials

<p>
US pharma major Pfizer Inc said on Friday it had withdrawn its application for emergency-use authorisation of its COVID-19 vaccine in India, after failing to comply with the drug regulator’s rules for carrying out a local safety and immunogenicity trial for the shots.</p>
<p>
The decision means the vaccine will not be available for sale in India in the near future.</p>
<p>
Unlike other companies such as Russia's Spuntik V who are carrying out trials in India for vaccines developed abroad, Pfizer had sought an exemption based on trials done in the United States and Germany.</p>
<p>
However, Indian rules stipulate domestic trials as well to determine if a vaccine is safe and generates an immune response in local citizens. There are, however, provisions under India’s rules to waive such trials in certain conditions.</p>
<p>
Central Drugs Standard Control Organisation said its experts did not recommend the vaccine because side effects reported abroad were still being investigated. It also said Pfizer had not proposed any plan to generate safety and immunogenicity data in India.</p>
<p>
Pfizer said, “Based on the deliberations at the meeting and our understanding of additional information that the regulator may need, the company has decided to withdraw its application at this time.”</p>
<p>
“Pfizer will continue to engage with the authority and re-submit its approval request with additional information as it becomes available in the near future,” the company said.</p>
<p>
Pfizer had sought authorisation for its vaccine in India late last year, but the government in January approved two much cheaper vaccines which are being produced in India. While one is being manufactured by Pune-based Serum Institute in collaboration with UK pharma giant AstraZeneca and Oxford University, the second has been developed in India by Bharat Biotech with the Indian Council of Medical Research. Both vaccines have been cleared for emergency use.</p>
<p>
Local company Dr. Reddy’s Laboratories Ltd is running trials for Russia’s Sputnik V vaccine, which is expected to be approved in the coming weeks. The vaccine has already been cleared for mass use in Russia.</p>

IN Bureau

Recent Posts

“Are there two laws in this world?”: Former Union Minister MJ Akbar raise concern over global inaction, hypocrisy on terrorism

Former Union Minister MJ Akbar, part of the all-party delegation led by BJP MP Ravi…

3 hours ago

PM Modi meets Australian Dy PM Marles; lauds 5 years of Strategic Partnership

New Delhi [India], June 4 (ANI): Prime Minister Narendra Modi met with Australian Deputy Prime…

3 hours ago

Relentless in Adversity: Indian Army leads search, rescue operations in North Sikkim

In the aftermath of the devastating landslide that struck North Sikkim, the Indian Army has…

5 hours ago

Google pauses ‘Ask Photos’ AI Feature to address performance issues

In a move that has raised eyebrows in the tech community, Google has decided to…

5 hours ago

Australian Defence Minister Marles makes first ‘port of call’ at ‘chai’ stall in Delhi

Tapping into a typical Indian habit of starting one's day with tea, Australia's Deputy Prime…

5 hours ago

Paank slams Pakistan over extrajudicial killings in Balochistan; bodies of abducted found in Kalat

Paank condemns the extrajudicial killings of Samiullah, son of Muhammad Hanif, and Bismillah, son of…

6 hours ago